CGTX COGNITION THERAPEUTICS INC
Nasdaq · SEC CIK 1455365 · EDGAR
- Bought, last 12 months
- $32.5K 3 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 99 since 2021-10-12, latest 2026-06-22 17:18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Doyle John Brendan | CFO | $11.3K | — |
| Caggiano Anthony | Chief Medical Off | $11.1K | — |
| Ricciardi Lisa | CEO, Pres, Dir | $10.1K | — |
| Wallace Peggy | Dir | — | — |
| Fletcher Aaron G.L. | Dir, 10% | — | — |
| Khattar Jack A. | Dir | — | — |
| Monia Brett P | Dir | — | — |
| RICHSTONE ELLEN B | Dir | — | — |
Transactions 104
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 17:18 | 2026-06-17 | CGTX | Khattar Jack A. | Dir | A - Grant | $0.00 | +25.0K | 73.5K | +52% | $0 | |
| 2026-06-22 17:16 | 2026-06-17 | CGTX | Monia Brett P | Dir | A - Grant | $0.00 | +25.0K | 73.5K | +52% | $0 | |
| 2026-06-22 17:14 | 2026-06-17 | CGTX | Wallace Peggy | Dir | A - Grant | $0.00 | +25.0K | 111.5K | +29% | $0 | |
| 2026-06-22 17:12 | 2026-06-17 | CGTX | RICHSTONE ELLEN B | Dir | A - Grant | $0.00 | +25.0K | 83.5K | +43% | $0 | |
| 2026-06-22 16:00 | 2026-06-17 | CGTX | Fletcher Aaron G.L. | Dir, 10% | A - Grant | $0.00 | +25.0K | 81.2K | +44% | $0 | |
| 2026-05-04 16:01 | 2026-05-01 | CGTX | Doyle John Brendan | CFO | F - Tax | $1.28 | -8,567 | 618.9K | -1% | -$11.0K | |
| 2026-04-20 16:18 | 2026-04-16 | CGTX | Doyle John Brendan | CFO | P - Purchase | $1.13 | +10.0K | 627.5K | +2% | +$11.3K | |
| 2026-04-20 16:16 | 2026-04-16 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $1.10 | +9,175 | 1.72M | +0.5% | +$10.1K | |
| 2026-04-20 16:15 | 2026-04-16 | CGTX | Caggiano Anthony | Chief Medical Off | P - Purchase | $1.11 | +10.0K | 874.9K | +1% | +$11.1K | |
| 2026-02-18 | 2026-02-15 | CGTX | Doyle John Brendan | CFO | F - Tax | $1.12 | -1,560 | 617.5K | -0.3% | -$1,747 | |
| 2026-02-18 | 2026-02-15 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $1.12 | -4,680 | 864.9K | -0.5% | -$5,242 | |
| 2026-02-18 | 2026-02-15 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $1.12 | -5,850 | 1.71M | -0.3% | -$6,552 | |
| M | 2026-02-05 | 2026-02-03+ | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $1.06 | -77.7K | 1.71M | -4% | -$82.4K |
| 2026-02-05 | 2026-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +800.0K | 1.79M | +81% | $0 | |
| 2026-02-05 | 2026-02-04 | CGTX | Doyle John Brendan | CFO | F - Tax | $1.03 | -26.9K | 619.1K | -4% | -$27.7K | |
| 2026-02-05 | 2026-02-03 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +200.0K | 646.0K | +45% | $0 | |
| M | 2026-02-05 | 2026-02-03+ | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $1.06 | -38.4K | 869.6K | -4% | -$40.6K |
| 2026-02-05 | 2026-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +400.0K | 908.0K | +79% | $0 | |
| 2025-12-22 | 2025-12-18 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $1.50 | -23.4K | 990.3K | -2% | -$35.1K | |
| 2025-12-22 | 2025-12-18 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +75.0K | 1.01M | +8% | $0 | |
| 2025-12-22 | 2025-12-18 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $1.50 | -20.3K | 508.0K | -4% | -$30.4K | |
| 2025-12-22 | 2025-12-18 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +65.0K | 528.3K | +14% | $0 | |
| 2025-12-22 | 2025-12-18 | CGTX | Doyle John Brendan | CFO | F - Tax | $1.50 | -9,360 | 446.0K | -2% | -$14.0K | |
| 2025-12-22 | 2025-12-18 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +30.0K | 455.4K | +7% | $0 | |
| D | 2025-09-23 | 2025-09-19 | CGTX | Fletcher Aaron G.L. | Dir, 10% | M - OptEx | $0.84 | +7,729 | 56.2K | +16% | +$6,492 |
| 2025-07-31 | 2025-07-29 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +30.0K | 434.7K | +7% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | Doyle John Brendan | CFO | F - Tax | $0.67 | -9,360 | 425.4K | -2% | -$6,271 | |
| 2025-07-31 | 2025-07-29 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $0.67 | -20.3K | 463.3K | -4% | -$13.6K | |
| 2025-07-31 | 2025-07-29 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +65.0K | 483.6K | +16% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +75.0K | 962.1K | +8% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $0.67 | -23.4K | 938.7K | -2% | -$15.7K | |
| 2025-06-23 | 2025-06-18 | CGTX | RICHSTONE ELLEN B | Dir | A - Grant | $0.00 | +34.0K | 58.5K | +139% | $0 | |
| 2025-06-23 | 2025-06-18 | CGTX | Wallace Peggy | Dir | A - Grant | $0.00 | +34.0K | 86.5K | +65% | $0 | |
| 2025-06-23 | 2025-06-18 | CGTX | Khattar Jack A. | Dir | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 | |
| 2025-06-23 | 2025-06-18 | CGTX | Monia Brett P | Dir | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 | |
| I | 2025-06-20 | 2025-06-18 | CGTX | BIOS Fund III, LP | Dir, 10% | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 |
| 2025-06-20 | 2025-06-18 | CGTX | BIOS Advisors GP, LLC | Dir, 10% | A - Grant | $0.00 | +34.0K | 48.5K | +234% | $0 | |
| 2025-05-02 | 2025-05-01 | CGTX | Doyle John Brendan | CFO | F - Tax | $0.45 | -9,692 | 404.7K | -2% | -$4,361 | |
| 2025-02-18 | 2025-02-15 | CGTX | Doyle John Brendan | CFO | F - Tax | $0.59 | -1,723 | 414.4K | -0.4% | -$1,017 | |
| 2025-02-18 | 2025-02-15 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $0.59 | -5,296 | 418.6K | -1% | -$3,125 | |
| 2025-02-18 | 2025-02-15 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $0.59 | -6,619 | 887.1K | -0.7% | -$3,905 | |
| 2025-02-04 | 2025-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $0.67 | -29.0K | 262.4K | -10% | -$19.4K | |
| 2025-02-04 | 2025-02-04 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +631.3K | 893.7K | +241% | $0 | |
| I | 2025-02-04 | 2025-01-31 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $0.77 | +38.9K | 38.9K | New | +$29.9K |
| 2025-02-04 | 2025-02-04 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +295.0K | 423.9K | +229% | $0 | |
| 2025-02-04 | 2025-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $0.67 | -12.8K | 128.8K | -9% | -$8,562 | |
| 2025-02-04 | 2025-02-04 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +295.0K | 416.1K | +244% | $0 | |
| DI | 2024-06-11 | 2024-06-07 | CGTX | Kreis Leslie W. | Dir, 10% | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| D | 2024-06-11 | 2024-06-07 | CGTX | Bios Equity Partners II, LP | Dir, 10% | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| D | 2024-06-11 | 2024-06-07 | CGTX | Wallace Peggy | Dir | A - Grant | $0.00 | +8,500 | 52.5K | +19% | $0 |
| D | 2024-06-11 | 2024-06-07 | CGTX | Khattar Jack A. | Dir | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| D | 2024-06-11 | 2024-06-07 | CGTX | Monia Brett P | Dir | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| D | 2024-06-11 | 2024-06-07 | CGTX | RICHSTONE ELLEN B | Dir | A - Grant | $0.00 | +8,500 | 24.5K | +53% | $0 |
| 2024-05-03 | 2024-05-01 | CGTX | Doyle John Brendan | CFO | F - Tax | $1.95 | -8,699 | 121.1K | -7% | -$17.0K | |
| 2024-03-14 | 2024-03-14 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $1.75 | +5,700 | 291.3K | +2% | +$9,975 | |
| D | 2024-02-20 | 2024-02-15 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +20.0K | 129.8K | +18% | $0 |
| D | 2024-02-20 | 2024-02-15 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +60.0K | 141.6K | +74% | $0 |
| D | 2024-02-20 | 2024-02-15 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +75.0K | 285.6K | +36% | $0 |
| 2024-02-09 | 2024-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | F - Tax | $2.29 | -27.8K | 210.6K | -12% | -$63.7K | |
| 2024-02-09 | 2024-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | F - Tax | $2.29 | -12.8K | 81.6K | -14% | -$29.3K | |
| I | 2023-11-13 | 2023-11-08 | CGTX | Fletcher Aaron G.L. | Dir, 10% | A - Grant | $1.05 | +500.1K | 500.1K | New | +$525.1K |
| I | 2023-11-13 | 2023-11-08 | CGTX | BIOS Fund III, LP | Dir, 10% | A - Grant | $1.05 | +500.1K | 500.1K | New | +$525.1K |
| DI | 2023-06-13 | 2023-06-09 | CGTX | BIOS Memory SPV II, LP | Dir, 10% | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | Monia Brett P | Dir | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | Khattar Jack A. | Dir | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | RICHSTONE ELLEN B | Dir | A - Grant | $0.00 | +6,000 | 16.0K | +60% | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | Wallace Peggy | Dir | A - Grant | $0.00 | +6,000 | 44.0K | +16% | $0 |
| D | 2023-06-13 | 2023-06-09 | CGTX | BIOS Fund I, LP | Dir, 10% | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
| D | 2023-05-03 | 2023-05-01 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +109.8K | 109.8K | New | $0 |
| D | 2023-02-07 | 2023-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +214.0K | 238.5K | +873% | $0 |
| D | 2023-02-07 | 2023-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +94.4K | 94.4K | New | $0 |
| MI | 2022-11-29 | 2022-11-28 | CGTX | BIOS Fund III QP, LP | Dir, 10% | P - Purchase | $2.65 | +16.1K | 326.7K | +5% | +$42.6K |
| MI | 2022-11-29 | 2022-11-28 | CGTX | BIOS Fund I QP, LP | Dir, 10% | P - Purchase | $2.65 | +16.1K | 326.7K | +5% | +$42.6K |
| 2022-11-29 | 2022-11-29 | CGTX | RICHSTONE ELLEN B | Dir | P - Purchase | $2.66 | +10.0K | 10.0K | New | +$26.6K | |
| MI | 2022-11-17 | 2022-11-16 | CGTX | BIOS Fund III NT, LP | 10% | P - Purchase | $1.40 | +71.0K | 324.8K | +28% | +$99.4K |
| MI | 2022-11-17 | 2022-11-16 | CGTX | BIOS Fund I, LP | 10% | P - Purchase | $1.40 | +71.0K | 324.8K | +28% | +$99.4K |
| MI | 2022-11-16 | 2022-11-15 | CGTX | BIOS Fund I QP, LP | 10% | P - Purchase | $1.20 | +1.50M | 316.0K | New | +$1.80M |
| 2022-11-16 | 2022-11-15 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $1.30 | +12.0K | 24.5K | +96% | +$15.6K | |
| 2022-11-16 | 2022-11-15 | CGTX | Wallace Peggy | Dir | P - Purchase | $1.20 | +12.5K | 38.0K | +49% | +$15.0K | |
| MI | 2022-11-16 | 2022-11-15 | CGTX | Cavu Management, LP | 10% | P - Purchase | $1.20 | +1.50M | 316.0K | New | +$1.80M |
| 2022-09-29 | 2022-09-27 | CGTX | Golden Seeds Cognition Therapeutics LLC | 10% | J - Other | $0.00 | -2.49M | 0 | -100% | $0 | |
| 2022-09-29 | 2022-09-27 | CGTX | Wallace Peggy | Dir | J - Other | $0.00 | +22.5K | 25.5K | +749% | $0 | |
| A | 2022-02-01 | 2021-10-13 | CGTX | BIOS Memory SPV I, LP | 10% | C - Cnv Deriv | — | +1.42M | 1.42M | New | — |
| AI | 2022-02-01 | 2021-10-13 | CGTX | Fletcher Aaron G.L. | Dir, 10% | C - Cnv Deriv | — | +1.42M | 1.42M | New | — |
| 2021-10-25 | 2021-10-13 | CGTX | Wallace Peggy | Dir | P - Purchase | $12.00 | +3,000 | 3,000 | New | +$36.0K | |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | Fletcher Aaron G.L. | Dir | C - Cnv Deriv | — | +3.69M | 755.4K | New | — |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | Fletcher Aaron G.L. | Dir | P - Purchase | $12.00 | +190.0K | 899.9K | +27% | +$2.28M |
| DI | 2021-10-15 | 2021-10-13 | CGTX | Fletcher Aaron G.L. | Dir | S - Sale+OE | $12.00 | -90.28 | 385.2K | -0.0% | -$1,083 |
| DI | 2021-10-15 | 2021-10-13 | CGTX | Fletcher Aaron G.L. | Dir | X - OptEx | $0.03 | +33.5K | 385.3K | +10% | +$1,005 |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | Breedlove Mark H. | Dir | C - Cnv Deriv | $0.03 | +404.5K | 44.8K | New | +$12.1K |
| DI | 2021-10-15 | 2021-10-13 | CGTX | Breedlove Mark H. | Dir | S - Sale | $12.00 | -11.74 | 404.4K | -0.0% | -$140.88 |
| DM | 2021-10-15 | 2021-10-13 | CGTX | Ogden CAP Associates, LLC | 10% | C - Cnv Deriv | — | +2.18M | 2.18M | New | — |
| D | 2021-10-15 | 2021-10-13 | CGTX | Ogden CAP Associates, LLC | 10% | X - OptEx | $0.03 | +27.5K | 2.21M | +1% | +$824.13 |
| D | 2021-10-15 | 2021-10-13 | CGTX | Ogden CAP Associates, LLC | 10% | S - Sale+OE | $12.00 | -74.05 | 2.21M | -0.0% | -$888.60 |
| DM | 2021-10-15 | 2021-10-13 | CGTX | Golden Seeds Cognition Therapeutics LLC | 10% | C - Cnv Deriv | — | +2.48M | 2.49M | +20,237% | — |
| D | 2021-10-15 | 2021-10-13 | CGTX | Golden Seeds Cognition Therapeutics LLC | 10% | X - OptEx | $0.03 | +12.3K | 2.18M | +0.6% | +$368.28 |
| D | 2021-10-15 | 2021-10-13 | CGTX | Golden Seeds Cognition Therapeutics LLC | 10% | S - Sale+OE | $12.00 | -33.09 | 2.18M | -0.0% | -$397.08 |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | BIOS Memory SPV I, LP | 10% | C - Cnv Deriv | — | +2.27M | 596.9K | New | — |
| D | 2021-10-15 | 2021-10-13 | CGTX | BIOS Memory SPV I, LP | 10% | C - Cnv Deriv | — | +1.42M | 1.42M | New | — |
| DMI | 2021-10-15 | 2021-10-13 | CGTX | BIOS Memory SPV I, LP | 10% | P - Purchase | $12.00 | +190.0K | 899.9K | +27% | +$2.28M |
Purchase Sale Sale after option exercise All abbreviations